Fondazione IRCCS Istituto Nazionale dei Tumori at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Fondazione IRCCS Istituto Nazionale dei Tumori takes part in 15 sessions at ESMO 2026 in Madrid. Its program centres on upper gastrointestinal cancers, including HER2-positive gastroesophageal adenocarcinoma and locally advanced liver cancer, along with lung cancer and oligometastatic head and neck cancer. Other sessions cover how oncologists can use and prompt generative artificial intelligence, and pathology in mixed neuroendocrine tumours.
| Organization | ESMO 2026 Attendance |
|---|---|
Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy | |
Public cancer hospital and scientific research institute in Milan, Italy. | Chair Fri Oct 23 13:30–15:00 Proffered paper 1: Gastrointestinal tumour, upper digestive Gastrointestinal cancers Abstract Fri Oct 23 14:00–14:12 Invited Discussant LBA77, LBA78 and 2875O Gastrointestinal cancers Chair Sat Oct 24 10:15–11:45 Chair Sat Oct 24 10:15–11:00 Integrating experiences in treating oligometastatic HNC patients Sarcoma, CNS, head & neck and rare cancers Talk Sat Oct 24 10:55–11:15 Talk Sat Oct 24 11:00–11:20 Radio-oncology perspective Lung & thoracic cancers Abstract Sat Oct 24 15:10–15:15 Talk Sat Oct 24 15:35–15:50 View of the surgeon Gastrointestinal cancers Abstract Sat Oct 24 15:50–16:02 Invited Discussant 3714O and 3716O Sarcoma, CNS, head & neck and rare cancers Talk Sat Oct 24 16:35–16:55 Minimum requirements in the pathology reports Sarcoma, CNS, head & neck and rare cancers Chair Sat Oct 24 18:30–20:00 ESMO Colloquium supported by Jazz Pharmaceuticals - Optimising the management of patients with advanced HER2+ gastroesophageal adenocarcinoma: ‘Testing’ the way to efficacy and safety Gastrointestinal cancersBiomarkers & precision oncology Talk Sat Oct 24 18:45–19:00 State of the art systemic therapy for patients with HER2+ metastatic gastroesophageal adenocarcinoma: When more is better? Gastrointestinal cancersBiomarkers & precision oncology Chair Sun Oct 25 14:45–16:15 Coming soon to your clinic? New therapies and approaches for lung cancer Lung & thoracic cancers Chair Sun Oct 25 14:45–16:15 State-of-the-art treatment for non metastatic upper GI cancers Gastrointestinal cancers Abstract Sun Oct 25 15:17–15:22 Talk Sun Oct 25 15:45–16:05 Talk Sun Oct 25 17:15–17:30 Can we personalise and de-escalate treatment strategies? Genitourinary cancers Chair Mon Oct 26 12:00–12:50 Talk Mon Oct 26 12:15–12:30 Chair Mon Oct 26 14:45–16:15 Rapid oral 2: Gastrointestinal tumour, upper digestive Gastrointestinal cancers Abstract Mon Oct 26 15:00–15:15 Invited Discussant LBA84, LBA85 and 3137RO Gastrointestinal cancers |
Instantly find 20 buyers from Fondazione IRCCS Istituto Nazionale dei Tumori
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction